UiPath Inc (NYSE: PATH): The Best-Of-Breed For Investing?

Currently, there are 486.82M common shares owned by the public and among those 430.73M shares have been available to trade.

However, the script later moved the day high at 25.05, down -2.12%. The company’s stock has a 5-day price change of -3.40% and -13.05% over the past three months. PATH shares are trading -10.67% year to date (YTD), with the 12-month market performance up to 34.08% higher. It has a 12-month low price of $12.38 and touched a high of $27.87 over the same period. PATH has an average intraday trading volume of 9.51 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.77%, -5.91%, and 12.99% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of UiPath Inc (NYSE: PATH) shares accounts for 58.27% of the company’s 486.82M shares outstanding.

It has a market capitalization of $12.56B and a beta (3y monthly) value of 0.96. The earnings-per-share (ttm) stands at -$0.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.76% over the week and 4.02% over the month.

Earnings per share for the fiscal year are expected to increase by 6.46%, and 17.94% over the next financial year. EPS should grow at an annualized rate of 46.20% over the next five years, compared to 20.57% over the past 5-year period.

Looking at the support for the PATH, a number of firms have released research notes about the stock. JP Morgan stated their Overweight rating for the stock in a research note on March 14, 2024, with the firm’s price target at $22-$28. Needham coverage for the UiPath Inc (PATH) stock in a research note released on March 14, 2024 offered a Buy rating with a price target of $30. Wells Fargo on their part issued Equal Weight rating on June 09, 2023.

Most Popular

Related Posts